Buprenorphine Rx Activity Varies Widely Among Clinicians
Less than 5 percent of prescribers account for half of all buprenorphine treatment in the country
FDA Approves Aduhelm for Alzheimer Disease
Agency says it has granted approval on the condition that drug maker Biogen conduct a new clinical trial
COVID-19 Had Major Impact on ICU Nurses’ Mental Health
Moderate-to-severe depression and anxiety reported for 44.6 and 31 percent, respectively; 47 percent were at risk for PTSD
Secondhand Smoke Exposure Linked to Odds of ADHD Symptoms
Odds of ADHD symptoms increased for children with exposure in prenatal period, early postnatal period, current period
Minority of Those With AUD Referred to, Receive Treatment
However, health care use and screening are common for alcohol use disorder
Physician’s Briefing Weekly Coronavirus Roundup
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
COVID-19 Pandemic Tied to Increase in Overdose Deaths
Weekly median overdose deaths increased by 50 percent after stay-at-home order
Key Factors ID’d for Bipolar Medication Nonadherence
Patients report side effects, beliefs, and knowledge about bipolar disorder are top reasons for not taking medications
Risk for Post-COVID-19 Clinical Sequelae Examined in Adults
Risk increased for new sequelae attributed to SARS-CoV-2 infection, including chronic respiratory failure, myocarditis, anxiety, fatigue
